Filing Details
- Accession Number:
- 0001209191-21-022178
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-03-19 19:55:45
- Reporting Period:
- 2021-03-17
- Accepted Time:
- 2021-03-19 19:55:45
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 353569 | Quidel Corp | QDEL | In Vitro & In Vivo Diagnostic Substances (2835) | 942573850 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1812662 | J. William Ferenczy | 9975 Summers Ridge Road San Diego CA 92121 | Svp, Cardio/Metabolic Unit | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-03-17 | 691 | $23.41 | 8,596 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2021-03-17 | 3,910 | $15.40 | 12,506 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-03-17 | 4,601 | $136.07 | 7,905 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-03-17 | 2,799 | $136.05 | 5,106 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Options | Disposition | 2021-03-17 | 691 | $0.00 | 691 | $23.41 |
| Common Stock | Non-Qualified Stock Options | Disposition | 2021-03-17 | 3,910 | $0.00 | 3,910 | $15.40 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 1,263 | 2025-02-05 | No | 4 | M | Direct | |
| 0 | 2026-02-10 | No | 4 | M | Direct |
Footnotes
- The amount of securities beneficially owned includes 595 shares not previously reported due to a clerical error.
- The weighted average sale price for these transactions was $136.0654 per share, with a range of $134.11 to $138.52. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares sold at each separate price.
- The weighted average sale price for these transactions was $136.0488 per share, with a range of $134.11 to $138.51. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares sold at each separate price.
- 977 shares vested on 02/05/2018 and 977 shares vested on 02/05/2019.
- 1,956 shares vested on 02/10/2018; 977 shares vested on 02/10/2019; and 977 shares vested on 02/10/2020.
Billionaire Hedge Funds
